Filed: 2/17/2026ACC: 0001974915-26-000002
📋 What this filing means
VESTAL POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 76 equity positions with a total reported market value of $2.94B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
76
Positions
$2.94B
Total AUM (reported)
117.96M
Total Shares
Allocation by class
COM$1.66B56.3%
SPONSORED ADS$264.41M9.0%
UNIT SER 1$215.01M7.3%
COMMON STOCK$190.71M6.5%
CL A$139.17M4.7%
COM SHS$122.67M4.2%
ORD SHS$93.87M3.2%
Portfolio Concentration
Top 3$661.94M22.5%
4–10$813.66M27.7%
11–25$823.68M28.0%
Rest$641.99M21.8%
Top 3 weight
22.5%
Top 10 weight
50.2%
Voting Authority Distribution
Total shares with voting rights: 117.96M
Sole
Full voting authority
117.96M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole76
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings76
Rows:
Abivax SA
SOLEShares1.90M
TypeSH
Market value$256.22M
8.71%
Sole
1.90M
Shared
0.00
None
0.00
Invesco QQQ Trust Series 1
SOLEShares350K
TypeSH
Market value$215.01M
7.31%
Sole
350K
Shared
0.00
None
0.00
Arcellx Inc
SOLEShares2.92M
TypeSH
Market value$190.71M
6.48%
Sole
2.92M
Shared
0.00
None
0.00
Terns Pharmaceuticals Inc
SOLEShares4.50M
TypeSH
Market value$181.80M
6.18%
Sole
4.50M
Shared
0.00
None
0.00
BioMarin Pharmaceutical Inc
SOLEShares3M
TypeSH
Market value$178.29M
6.06%
Sole
3M
Shared
0.00
None
0.00
Globus Medical Inc
SOLEShares1.27M
TypeSH
Market value$111.32M
3.78%
Sole
1.27M
Shared
0.00
None
0.00
Nurix Therapeutics Inc
SOLEShares4.69M
TypeSH
Market value$88.97M
3.02%
Sole
4.69M
Shared
0.00
None
0.00
Alcon AG
SOLEShares1.10M
TypeSH
Market value$87.09M
2.96%
Sole
1.10M
Shared
0.00
None
0.00
Dexcom Inc
SOLEShares1.27M
TypeSH
Market value$84.62M
2.88%
Sole
1.27M
Shared
0.00
None
0.00
Merck & Co Inc
SOLEShares775K
TypeSH
Market value$81.58M
2.77%
Sole
775K
Shared
0.00
None
0.00
Taysha Gene Therapies Inc
SOLEShares13.75M
TypeSH
Market value$75.63M
2.57%
Sole
13.75M
Shared
0.00
None
0.00
Abbott Laboratories
SOLEShares600K
TypeSH
Market value$75.17M
2.56%
Sole
600K
Shared
0.00
None
0.00
Immatics NV
SOLEShares6.13M
TypeSH
Market value$64.31M
2.19%
Sole
6.13M
Shared
0.00
None
0.00
Tyra Biosciences Inc
SOLEShares2.42M
TypeSH
Market value$63.75M
2.17%
Sole
2.42M
Shared
0.00
None
0.00
Bicara Therapeutics Inc
SOLEShares3.58M
TypeSH
Market value$60.17M
2.05%
Sole
3.58M
Shared
0.00
None
0.00
Arrowhead Pharmaceuticals Inc
SOLEShares900K
TypeSH
Market value$59.75M
2.03%
Sole
900K
Shared
0.00
None
0.00
Enliven Therapeutics Inc
SOLEShares3.83M
TypeSH
Market value$58.98M
2.01%
Sole
3.83M
Shared
0.00
None
0.00
Disc Medicine Inc
SOLEShares735K
TypeSH
Market value$58.37M
1.98%
Sole
735K
Shared
0.00
None
0.00
Jazz Pharmaceuticals PLC
SOLEShares290K
TypeSH
Market value$49.30M
1.68%
Sole
290K
Shared
0.00
None
0.00
Day One Biopharmaceuticals Inc
SOLEShares5.20M
TypeSH
Market value$48.46M
1.65%
Sole
5.20M
Shared
0.00
None
0.00
Lexeo Therapeutics Inc
SOLEShares4.47M
TypeSH
Market value$44.44M
1.51%
Sole
4.47M
Shared
0.00
None
0.00
Alto Neuroscience Inc
SOLEShares2.48M
TypeSH
Market value$44.23M
1.50%
Sole
2.48M
Shared
0.00
None
0.00
Apogee Therapeutics Inc
SOLEShares550K
TypeSH
Market value$41.51M
1.41%
Sole
550K
Shared
0.00
None
0.00
Olema Pharmaceuticals Inc
SOLEShares1.65M
TypeSH
Market value$41.25M
1.40%
Sole
1.65M
Shared
0.00
None
0.00
Axsome Therapeutics Inc
SOLEShares210K
TypeSH
Market value$38.35M
1.30%
Sole
210K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Abivax SASOLE | SPONSORED ADS | 1.90M | SH | $256.22M 8.71% | 1.90M | 0.00 | 0.00 |
Invesco QQQ Trust Series 1SOLE | UNIT SER 1 | 350K | SH | $215.01M 7.31% | 350K | 0.00 | 0.00 |
Arcellx IncSOLE | COMMON STOCK | 2.92M | SH | $190.71M 6.48% | 2.92M | 0.00 | 0.00 |
Terns Pharmaceuticals IncSOLE | COM | 4.50M | SH | $181.80M 6.18% | 4.50M | 0.00 | 0.00 |
BioMarin Pharmaceutical IncSOLE | COM | 3M | SH | $178.29M 6.06% | 3M | 0.00 | 0.00 |
Globus Medical IncSOLE | CL A | 1.27M | SH | $111.32M 3.78% | 1.27M | 0.00 | 0.00 |
Nurix Therapeutics IncSOLE | COM | 4.69M | SH | $88.97M 3.02% | 4.69M | 0.00 | 0.00 |
Alcon AGSOLE | ORD SHS | 1.10M | SH | $87.09M 2.96% | 1.10M | 0.00 | 0.00 |
Dexcom IncSOLE | COM | 1.27M | SH | $84.62M 2.88% | 1.27M | 0.00 | 0.00 |
Merck & Co IncSOLE | COM | 775K | SH | $81.58M 2.77% | 775K | 0.00 | 0.00 |
Taysha Gene Therapies IncSOLE | COM SHS | 13.75M | SH | $75.63M 2.57% | 13.75M | 0.00 | 0.00 |
Abbott LaboratoriesSOLE | COM | 600K | SH | $75.17M 2.56% | 600K | 0.00 | 0.00 |
Immatics NVSOLE | SHS | 6.13M | SH | $64.31M 2.19% | 6.13M | 0.00 | 0.00 |
Tyra Biosciences IncSOLE | COM | 2.42M | SH | $63.75M 2.17% | 2.42M | 0.00 | 0.00 |
Bicara Therapeutics IncSOLE | COM | 3.58M | SH | $60.17M 2.05% | 3.58M | 0.00 | 0.00 |
Arrowhead Pharmaceuticals IncSOLE | COM | 900K | SH | $59.75M 2.03% | 900K | 0.00 | 0.00 |
Enliven Therapeutics IncSOLE | COM | 3.83M | SH | $58.98M 2.01% | 3.83M | 0.00 | 0.00 |
Disc Medicine IncSOLE | COM | 735K | SH | $58.37M 1.98% | 735K | 0.00 | 0.00 |
Jazz Pharmaceuticals PLCSOLE | SHS USD | 290K | SH | $49.30M 1.68% | 290K | 0.00 | 0.00 |
Day One Biopharmaceuticals IncSOLE | COM | 5.20M | SH | $48.46M 1.65% | 5.20M | 0.00 | 0.00 |
Lexeo Therapeutics IncSOLE | COM | 4.47M | SH | $44.44M 1.51% | 4.47M | 0.00 | 0.00 |
Alto Neuroscience IncSOLE | COM SHS | 2.48M | SH | $44.23M 1.50% | 2.48M | 0.00 | 0.00 |
Apogee Therapeutics IncSOLE | COM | 550K | SH | $41.51M 1.41% | 550K | 0.00 | 0.00 |
Olema Pharmaceuticals IncSOLE | COM | 1.65M | SH | $41.25M 1.40% | 1.65M | 0.00 | 0.00 |
Axsome Therapeutics IncSOLE | COM | 210K | SH | $38.35M 1.30% | 210K | 0.00 | 0.00 |
Page 1 of 4